Absci Corp (ABSI)

Jan 13, 2025, 2:05 AM EST - 4 days ago

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

AMD

Jan 10, 2025, 7:30 AM EST - 7 days ago

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Jan 8, 2025, 7:00 AM EST - 9 days ago

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Jan 6, 2025, 8:00 AM EST - 11 days ago

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Nov 12, 2024, 10:01 AM EST - 2 months ago

Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 7:30 AM EST - 2 months ago

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Nov 7, 2024, 8:00 AM EST - 2 months ago

Absci to Host R&D Day on December 12, 2024

Oct 15, 2024, 8:00 AM EDT - 3 months ago

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Oct 3, 2024, 12:36 PM EDT - 3 months ago

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Aug 21, 2024, 8:00 AM EDT - 5 months ago

Absci to Participate in Upcoming Investor Conferences

Aug 16, 2024, 11:50 PM EDT - 5 months ago

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:01 PM EDT - 5 months ago

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Aug 12, 2024, 8:00 AM EDT - 5 months ago

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Jul 28, 2024, 1:24 AM EDT - 6 months ago

Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships

Jul 10, 2024, 8:00 AM EDT - 6 months ago

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Jul 3, 2024, 4:00 PM EDT - 7 months ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 28, 2024, 8:00 AM EDT - 8 months ago

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 14, 2024, 1:30 PM EDT - 8 months ago

Absci Corporation (ABSI) Q1 2024 Earnings Call Transcript

May 14, 2024, 7:30 AM EDT - 8 months ago

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

Mar 21, 2024, 7:30 AM EDT - 10 months ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Mar 1, 2024, 4:01 PM EST - 11 months ago

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Feb 27, 2024, 10:20 PM EST - 11 months ago

Absci Announces Pricing of Public Offering of Common Stock

Feb 27, 2024, 4:01 PM EST - 11 months ago

Absci Announces Proposed Public Offering of Common Stock

Feb 21, 2024, 7:30 AM EST - 11 months ago

Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI

Jan 10, 2024, 7:30 AM EST - 1 year ago

Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Jan 3, 2024, 8:00 AM EST - 1 year ago

Absci to Participate in the 26th Annual Needham Growth Conference

Dec 28, 2023, 8:00 AM EST - 1 year ago

Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Dec 20, 2023, 7:30 AM EST - 1 year ago

Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline

Dec 4, 2023, 7:30 AM EST - 1 year ago

Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate

Dec 3, 2023, 1:28 AM EST - 1 year ago

AstraZeneca, AI biologics firm Absci tie up on cancer drug - FT

AZN

Nov 15, 2023, 8:00 AM EST - 1 year ago

Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference

Nov 14, 2023, 4:05 PM EST - 1 year ago

Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results

Nov 14, 2023, 2:16 AM EST - 1 year ago

Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases

Sep 21, 2023, 8:00 AM EDT - 1 year ago

Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen

Sep 6, 2023, 8:00 AM EDT - 1 year ago

Absci to Host R&D Day on October 4, 2023

Sep 5, 2023, 10:40 AM EDT - 1 year ago

Biotech company Absci lays off 30 employees, about 15% of staff

Aug 14, 2023, 8:02 AM EDT - 1 year ago

Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results

Aug 14, 2023, 8:00 AM EDT - 1 year ago

Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer

Aug 10, 2023, 8:00 AM EDT - 1 year ago

Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development

Aug 1, 2023, 8:00 AM EDT - 1 year ago

Absci to Participate in the UBS MedTech, Tools and Genomics Summit 2023

Jun 15, 2023, 8:00 AM EDT - 1 year ago

Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit

Jun 6, 2023, 8:00 AM EDT - 1 year ago

Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips

May 15, 2023, 4:05 PM EDT - 1 year ago

Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results

May 11, 2023, 8:00 AM EDT - 1 year ago

University of Oxford's Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies

Apr 6, 2023, 8:00 AM EDT - 1 year ago

Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference

Mar 30, 2023, 4:05 PM EDT - 1 year ago

Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

Mar 23, 2023, 8:00 AM EDT - 1 year ago

Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation

Mar 7, 2023, 8:00 AM EST - 2 years ago

Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Feb 28, 2023, 8:08 AM EST - 2 years ago

Absci Takes Its Generative AI Antibody Design Platform To Europe

Feb 21, 2023, 8:00 AM EST - 2 years ago

Absci to Participate in the 43rd Annual Cowen Health Care Conference